Bio-Path Holdings, Inc. (BPTH)
NASDAQ: BPTH · Real-Time Price · USD
0.820
+0.021 (2.63%)
Nov 22, 2024, 4:00 PM EST - Market closed
Bio-Path Holdings Employees
Bio-Path Holdings had 10 employees as of December 31, 2023. The number of employees did not change compared to the previous year.
Employees
10
Change (1Y)
n/a
Growth (1Y)
n/a
Revenue / Employee
n/a
Profits / Employee
-$1,051,300
Market Cap
3.53M
Employees Chart
Related Stocks
Company Name | Employees |
---|---|
NovaBay Pharmaceuticals | 26 |
Azitra | 10 |
Palisade Bio | 9 |
Artelo Biosciences | 6 |
TNF Pharmaceuticals | 6 |
Synaptogenix | 5 |
Lixte Biotechnology Holdings | 4 |
Cyclerion Therapeutics | 1 |
BPTH News
- 7 days ago - Bio-Path Holdings, Inc. (BPTH) Q3 2024 Earnings Call Transcript - Seeking Alpha
- 7 days ago - Bio-Path Holdings Reports Third Quarter 2024 Financial Results - GlobeNewsWire
- 14 days ago - Bio-Path Holdings to Announce Third Quarter 2024 Financial Results on November 15, 2024 - GlobeNewsWire
- 6 weeks ago - Bio-Path Holdings Announces Closing of $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 6 weeks ago - Bio-Path Holdings Announces $4.0 Million Private Placement Priced At-the-Market Under Nasdaq Rules - GlobeNewsWire
- 6 weeks ago - Bio-Path Holdings Initiates Development of Therapeutic Program for Treatment of Obesity - GlobeNewsWire
- 2 months ago - Stonegate Capital Partners Updates Coverage on Bio-Path Holdings, Inc. (BPTH) Q2 24 - Newsfile Corp
- 2 months ago - Bio-Path Holdings to Present at H.C. Wainwright 26th Annual Global Investment Conference - GlobeNewsWire